Merck shares rose 1.27% in premarket trading.

Tiger Newspress2021-12-22

Merck and Ridgeback Biotherapeutics announce that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.

In the U.K., Lagevrio is the planned trademark for molnupiravir.

This additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.

In early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.

Also, Merck has entered into a procurement agreement with the U.S. to supply ~3.1M courses of molnupiravi rand to deliver 1.6M courses to Japan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

SSVC
2021-12-23
SSVC
Good Appreciate your response and comments Thanks
- SSVC:
  [Strong][ShakeHands]
- Alfred1007:
  looks stable..one of the top biopharma companies in the world.
Success88
2021-12-23
Success88
Good
BoonHuat
2021-12-22
BoonHuat
Nice!
TK360
2021-12-22
TK360
Nice
CHOOTC
2021-12-22
CHOOTC
👍
ppp00
2021-12-22
ppp00
Please help to like
- S土豪熊貓G:
  Ok
- JeremyKok:
  hi. please help like and comment back. thank you.

Leave a comment

112

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1161411666?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-12-22 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161411666","market":"us","top_or_hot":-1,"title":"Merck shares rose 1.27% in premarket trading.","media":"Tiger Newspress","content":"<p>Merck&nbsp;shares&nbsp;rose&nbsp;1.27%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3b18c28ab1d788666cf1906ea7ed9844\" tg-width=\"716\" tg-height=\"589\" referrerpolicy=\"no-referrer\"></p>\n<p>Merck&nbsp;and Ridgeback Biotherapeutics&nbsp;announce&nbsp;that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.</p>\n<p>In the U.K., Lagevrio is the planned trademark for molnupiravir.</p>\n<p>This additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.</p>\n<p>In early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.</p>\n<p>Also, Merck &nbsp;has entered into a procurement agreement with the&nbsp;U.S. to supply ~3.1M courses of molnupiravi&nbsp;rand to&nbsp;deliver 1.6M courses to Japan.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck shares rose 1.27% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck shares rose 1.27% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n2021-12-22 20:01 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck shares rose 1.27% in premarket trading.\nMerck and Ridgeback Biotherapeutics announce that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an ...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRK","symbol_name":"默沙东","start_time":0,"source_url":null,"article_id":"1161411666","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161411666","pubTimestamp":1640174499,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Merck shares rose 1.27% in premarket trading.\nMerck and Ridgeback Biotherapeutics announce that the ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRK":"默沙东"},"translate_title":"默沙东股价在盘前交易中上涨1.27%。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9},"content_text":"Merck shares rose 1.27% in premarket trading.\nMerck and Ridgeback Biotherapeutics announce that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.\nIn the U.K., Lagevrio is the planned trademark for molnupiravir.\nThis additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.\nIn early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.\nAlso, Merck  has entered into a procurement agreement with the U.S. to supply ~3.1M courses of molnupiravi rand to deliver 1.6M courses to Japan.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":691561069,"gmtCreate":1640221538008,"gmtModify":1676532425542,"author":{"id":"3574906731000207","authorId":"3574906731000207","name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Good Appreciate your response and comments Thanks&nbsp;","listText":"Good Appreciate your response and comments Thanks&nbsp;","text":"Good Appreciate your response and comments Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/691561069","repostId":1161411666,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7085799,"gmtCreate":1640227272149,"gmtModify":1663239091232,"authorId":3574906731000207,"author":{"id":3574906731000207,"authorId":3574906731000207,"name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691561069,"type":1,"supId":7084194,"prevId":0,"content":"[Strong][ShakeHands]","text":"[Strong][ShakeHands]","html":"[Strong][ShakeHands]"},{"id":7084194,"gmtCreate":1640222695948,"gmtModify":1663239083440,"authorId":3570656625926041,"author":{"id":3570656625926041,"authorId":3570656625926041,"name":"Alfred1007","avatar":"https://static.tigerbbs.com/81d8406380cbc0525927f00a9510f2fa","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691561069,"type":1,"supId":0,"prevId":0,"content":"looks stable..one of the top biopharma companies in the world.","text":"looks stable..one of the top biopharma companies in the world.","html":"looks stable..one of the top biopharma companies in the world."}],"langContent":"CN"},{"id":9000266988,"gmtCreate":1640215265179,"gmtModify":1676533507340,"author":{"id":"4101948424484190","authorId":"4101948424484190","name":"Success88","avatar":"https://static.itradeup.com/news/4408e1a22d73e99adb53aa65dde8ad91","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":0},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000266988","repostId":1161411666,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9000641134,"gmtCreate":1640178214839,"gmtModify":1676533504970,"author":{"id":"3574549633778650","authorId":"3574549633778650","name":"BoonHuat","avatar":"https://static.tigerbbs.com/f64154b666040668c472fc3731becde7","vip":1,"crmLevel":6,"crmLevelSwitch":1},"htmlText":"Nice!","listText":"Nice!","text":"Nice!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000641134","repostId":1161411666,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":691608121,"gmtCreate":1640177947047,"gmtModify":1676532417964,"author":{"id":"3574766349354741","authorId":"3574766349354741","name":"TK360","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/691608121","repostId":1161411666,"repostType":4,"repost":{"id":"1161411666","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640174499,"share":"https://www.laohu8.com/m/news/1161411666?lang=&edition=full","pubTime":"2021-12-22 20:01","market":"us","language":"en","title":"Merck shares rose 1.27% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1161411666","media":"Tiger Newspress","summary":"Merck shares rose 1.27% in premarket trading.\nMerck and Ridgeback Biotherapeutics announce that the ","content":"<p>Merck&nbsp;shares&nbsp;rose&nbsp;1.27%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3b18c28ab1d788666cf1906ea7ed9844\" tg-width=\"716\" tg-height=\"589\" referrerpolicy=\"no-referrer\"></p>\n<p>Merck&nbsp;and Ridgeback Biotherapeutics&nbsp;announce&nbsp;that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.</p>\n<p>In the U.K., Lagevrio is the planned trademark for molnupiravir.</p>\n<p>This additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.</p>\n<p>In early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.</p>\n<p>Also, Merck &nbsp;has entered into a procurement agreement with the&nbsp;U.S. to supply ~3.1M courses of molnupiravi&nbsp;rand to&nbsp;deliver 1.6M courses to Japan.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck shares rose 1.27% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck shares rose 1.27% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-22 20:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Merck&nbsp;shares&nbsp;rose&nbsp;1.27%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/3b18c28ab1d788666cf1906ea7ed9844\" tg-width=\"716\" tg-height=\"589\" referrerpolicy=\"no-referrer\"></p>\n<p>Merck&nbsp;and Ridgeback Biotherapeutics&nbsp;announce&nbsp;that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.</p>\n<p>In the U.K., Lagevrio is the planned trademark for molnupiravir.</p>\n<p>This additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.</p>\n<p>In early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.</p>\n<p>Also, Merck &nbsp;has entered into a procurement agreement with the&nbsp;U.S. to supply ~3.1M courses of molnupiravi&nbsp;rand to&nbsp;deliver 1.6M courses to Japan.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161411666","content_text":"Merck shares rose 1.27% in premarket trading.\nMerck and Ridgeback Biotherapeutics announce that the U.K. Government will purchase an additional 1.75M patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine.\nIn the U.K., Lagevrio is the planned trademark for molnupiravir.\nThis additional procurement agreement follows a previous deal for 480K courses of treatment by U.K., totalling up to 2.23M courses of molnupiravir.\nIn early November,U.K.'s regulatory agency authorized Merck's COVID-19 pill.\nAlso, Merck  has entered into a procurement agreement with the U.S. to supply ~3.1M courses of molnupiravi rand to deliver 1.6M courses to Japan.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":9000649622,"gmtCreate":1640176988488,"gmtModify":1676533504918,"author":{"id":"3567209681027469","authorId":"3567209681027469","name":"CHOOTC","avatar":"https://static.tigerbbs.com/a825ae81d7f171dbbad58815b5ddda79","vip":1,"crmLevel":2,"crmLevelSwitch":1},"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000649622","repostId":1161411666,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":691878944,"gmtCreate":1640176264196,"gmtModify":1676532417641,"author":{"id":"3584224743159029","authorId":"3584224743159029","name":"ppp00","avatar":"https://static.tigerbbs.com/da2244bab9d4a7395c345d07997e6f44","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1},"htmlText":"Please help to like&nbsp;","listText":"Please help to like&nbsp;","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/691878944","repostId":1161411666,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":100016114,"gmtCreate":1640178620274,"gmtModify":1663241464149,"authorId":3578811676095048,"author":{"id":3578811676095048,"authorId":3578811676095048,"name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691878944,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":7082258,"gmtCreate":1640216618284,"gmtModify":1663239073257,"authorId":3567307840510045,"author":{"id":3567307840510045,"authorId":3567307840510045,"name":"JeremyKok","avatar":"https://static.tigerbbs.com/01b03a485f83b6b2615fad8ac9b87bf4","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691878944,"type":1,"supId":0,"prevId":0,"content":"hi. please help like and comment back. thank you.","text":"hi. please help like and comment back. thank you.","html":"hi. please help like and comment back. thank you."}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":112,"commentSize":18,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161411666"}